To the best of our knowledge, this is the second study to have reported this long survival rate for patients with EGFRmut NSCLC treated with first- and second-generation EGFR TKIs, and none of the previous studies reported long-term survival rates for patients with and without LM. Here, EGFR is linked to non-small cell lung carcinoma.